Header Logo

Annabelle Santos Volgman

Concepts (370)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
133
7.890
Why?
Cardiovascular Diseases
22
2024
349
5.670
Why?
Stroke
21
2023
272
4.450
Why?
Heart Failure
8
2023
173
2.620
Why?
Female
79
2024
15583
2.110
Why?
Transcatheter Aortic Valve Replacement
4
2023
20
2.020
Why?
Humans
104
2024
28117
2.010
Why?
Aortic Valve Stenosis
4
2023
23
2.010
Why?
Anticoagulants
7
2022
90
1.960
Why?
Myocardial Infarction
11
2023
140
1.830
Why?
Risk Factors
32
2024
2375
1.750
Why?
Healthcare Disparities
6
2020
88
1.710
Why?
Coronary Artery Disease
8
2022
138
1.700
Why?
Sex Factors
18
2022
475
1.630
Why?
Pregnancy Complications, Cardiovascular
6
2023
16
1.570
Why?
Hospital Mortality
8
2023
146
1.540
Why?
Cardiologists
2
2023
8
1.530
Why?
Exercise
7
2022
464
1.410
Why?
Cardiology
5
2022
55
1.400
Why?
Cognitive Dysfunction
6
2024
1035
1.370
Why?
Risk Assessment
14
2022
665
1.350
Why?
Sex Characteristics
7
2023
123
1.300
Why?
Hospitalization
8
2021
320
1.280
Why?
Women's Health
4
2020
178
1.250
Why?
Life Style
8
2020
197
1.240
Why?
Myocardial Ischemia
4
2022
43
1.240
Why?
Aged
41
2024
9223
1.190
Why?
Male
48
2023
15173
1.180
Why?
Primary Prevention
4
2022
33
1.170
Why?
Acute Kidney Injury
3
2023
45
1.170
Why?
Cardiovascular System
3
2022
15
1.150
Why?
Quality of Life
8
2023
656
1.140
Why?
United States
27
2023
2161
1.130
Why?
Physicians, Women
3
2022
17
1.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
60
1.090
Why?
Pacemaker, Artificial
3
2023
22
1.050
Why?
Arrhythmias, Cardiac
6
2019
69
1.020
Why?
Catheter Ablation
3
2022
72
1.010
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
26
0.970
Why?
Adrenergic beta-Antagonists
2
2020
28
0.970
Why?
Health Status Disparities
4
2019
75
0.950
Why?
Defibrillators, Implantable
3
2021
12
0.950
Why?
Middle Aged
33
2024
9188
0.940
Why?
Anti-Arrhythmia Agents
7
2022
34
0.930
Why?
American Heart Association
4
2023
18
0.890
Why?
Ischemic Attack, Transient
2
2023
18
0.870
Why?
Terminal Care
1
2023
27
0.830
Why?
Echocardiography, Doppler, Color
2
2019
13
0.820
Why?
Heart Defects, Congenital
1
2023
35
0.800
Why?
Myocarditis
1
2022
13
0.800
Why?
Premature Birth
1
2022
12
0.800
Why?
Electrocardiography
7
2015
109
0.770
Why?
Pregnancy
9
2023
341
0.770
Why?
Coronavirus
1
2021
2
0.740
Why?
Breast Neoplasms
3
2021
417
0.740
Why?
Length of Stay
4
2020
328
0.730
Why?
Chest Pain
1
2020
19
0.700
Why?
Brain Ischemia
1
2021
63
0.700
Why?
Intersectoral Collaboration
1
2020
7
0.700
Why?
Endothelium
1
2020
13
0.690
Why?
Vascular Diseases
1
2020
45
0.670
Why?
Social Media
1
2021
47
0.670
Why?
Patient Care Management
2
2021
19
0.670
Why?
Takotsubo Cardiomyopathy
1
2019
12
0.670
Why?
Treatment Outcome
14
2023
3531
0.660
Why?
Ambulatory Care Facilities
2
2022
40
0.650
Why?
Myxoma
1
2019
4
0.650
Why?
Cardiomyopathies
1
2019
32
0.650
Why?
Heart Neoplasms
1
2019
12
0.640
Why?
Cognition
4
2024
1354
0.640
Why?
Comorbidity
5
2021
497
0.640
Why?
Hypertension
7
2023
225
0.640
Why?
Betacoronavirus
1
2020
77
0.640
Why?
Heart Diseases
1
2020
68
0.630
Why?
Age Factors
8
2021
790
0.630
Why?
Heart Failure, Diastolic
1
2018
2
0.630
Why?
Women's Health Services
1
2018
9
0.620
Why?
Prevalence
6
2020
466
0.620
Why?
Heart Ventricles
1
2019
102
0.610
Why?
Culturally Competent Care
1
2018
11
0.610
Why?
Warfarin
3
2016
26
0.600
Why?
Delivery of Health Care, Integrated
1
2018
25
0.600
Why?
Coronavirus Infections
1
2020
91
0.600
Why?
Pneumonia, Viral
1
2020
95
0.600
Why?
Emigrants and Immigrants
1
2018
24
0.600
Why?
Antineoplastic Agents
1
2020
190
0.590
Why?
Atherosclerosis
1
2018
54
0.570
Why?
Prognosis
7
2021
819
0.520
Why?
Lipoprotein(a)
1
2016
5
0.520
Why?
Dyslipidemias
1
2016
16
0.510
Why?
Biomarkers
5
2024
583
0.500
Why?
Health Knowledge, Attitudes, Practice
2
2022
186
0.500
Why?
Diabetes Mellitus
3
2022
137
0.500
Why?
Electrodes
1
2015
12
0.490
Why?
Secondary Prevention
3
2022
54
0.480
Why?
Cost of Illness
1
2015
53
0.480
Why?
Social Support
1
2016
215
0.470
Why?
Adult
15
2023
8036
0.450
Why?
Magnetic Resonance Imaging
1
2019
1181
0.450
Why?
Electric Countershock
6
2020
10
0.440
Why?
Patient Readmission
3
2019
132
0.440
Why?
Aged, 80 and over
9
2021
4846
0.440
Why?
Aspirin
2
2020
84
0.440
Why?
Aortic Valve
3
2023
26
0.430
Why?
Non-ST Elevated Myocardial Infarction
3
2022
3
0.410
Why?
Retrospective Studies
10
2022
3537
0.410
Why?
ST Elevation Myocardial Infarction
3
2022
9
0.410
Why?
Atrial Appendage
2
2022
37
0.390
Why?
Cross-Sectional Studies
6
2024
929
0.380
Why?
Coronary Angiography
3
2020
76
0.380
Why?
Patient Acceptance of Health Care
1
2012
80
0.380
Why?
Alzheimer Disease
1
2023
2123
0.360
Why?
Frailty
2
2022
35
0.350
Why?
Cardiac Resynchronization Therapy Devices
2
2019
5
0.340
Why?
Cardiovascular Agents
2
2021
28
0.340
Why?
Hospital Costs
2
2020
64
0.330
Why?
Feasibility Studies
2
2020
231
0.330
Why?
Practice Guidelines as Topic
3
2021
316
0.310
Why?
Heart Atria
2
2019
28
0.290
Why?
Ventricular Fibrillation
2
2021
14
0.290
Why?
Percutaneous Coronary Intervention
3
2022
25
0.280
Why?
Cohort Studies
5
2023
1890
0.260
Why?
Health Status
2
2018
227
0.250
Why?
Administration, Oral
3
2016
110
0.250
Why?
Randomized Controlled Trials as Topic
5
2020
320
0.250
Why?
Societies, Medical
3
2023
153
0.250
Why?
Sex Distribution
3
2019
82
0.240
Why?
Palliative Care
2
2023
109
0.240
Why?
Antihypertensive Agents
2
2020
72
0.240
Why?
Hemorrhage
5
2020
81
0.240
Why?
Risk Adjustment
2
2021
11
0.230
Why?
Incidence
4
2020
757
0.230
Why?
Logistic Models
3
2021
397
0.230
Why?
Obesity
4
2020
311
0.230
Why?
Hospital Charges
2
2020
16
0.220
Why?
Leadership
2
2022
106
0.220
Why?
Illinois
2
2021
246
0.220
Why?
Young Adult
3
2020
2048
0.220
Why?
Cost-Benefit Analysis
2
2022
132
0.210
Why?
Cardiotoxicity
2
2020
8
0.210
Why?
Age Distribution
2
2020
89
0.210
Why?
Insulin-Like Growth Factor I
1
2024
58
0.210
Why?
Minority Groups
1
2023
81
0.210
Why?
Maternal Mortality
1
2023
7
0.210
Why?
Pulmonary Veins
1
2023
27
0.210
Why?
Morbidity
2
2019
58
0.210
Why?
Health Promotion
2
2016
160
0.210
Why?
Death
1
2023
47
0.210
Why?
Out-of-Hospital Cardiac Arrest
1
2022
8
0.200
Why?
Philippines
1
2022
4
0.200
Why?
Pregnant Women
1
2022
15
0.200
Why?
Pregnancy Outcome
1
2022
18
0.200
Why?
Cesarean Section
1
2022
31
0.200
Why?
Polypharmacy
1
2022
7
0.200
Why?
Vitamin K
1
2022
7
0.200
Why?
Attitude
1
2022
36
0.200
Why?
Sotalol
1
2021
1
0.200
Why?
Adolescent
2
2020
2291
0.200
Why?
Venous Thromboembolism
1
2022
36
0.200
Why?
Coronary Circulation
2
2020
25
0.190
Why?
Prospective Studies
3
2023
1763
0.190
Why?
Pandemics
2
2023
257
0.190
Why?
Cardiac Electrophysiology
1
2021
2
0.190
Why?
Troponin
1
2021
8
0.190
Why?
Sexism
1
2021
7
0.190
Why?
Shock, Cardiogenic
1
2021
7
0.190
Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.190
Why?
Water-Electrolyte Imbalance
1
2021
2
0.190
Why?
Death, Sudden, Cardiac
1
2021
14
0.190
Why?
Hormones
1
2021
11
0.190
Why?
Telemedicine
1
2023
110
0.190
Why?
Alcohol Drinking
1
2022
78
0.190
Why?
Overweight
1
2022
71
0.190
Why?
Women's Rights
1
2021
2
0.180
Why?
National Institutes of Health (U.S.)
1
2021
25
0.180
Why?
Sleep Apnea, Obstructive
1
2022
64
0.180
Why?
Signal Processing, Computer-Assisted
2
1998
32
0.180
Why?
Angioplasty
1
2020
6
0.180
Why?
Peripheral Arterial Disease
1
2020
6
0.180
Why?
Weight Loss
1
2022
126
0.180
Why?
Health Expenditures
1
2020
18
0.180
Why?
Career Choice
1
2021
30
0.180
Why?
Heart Valve Diseases
1
2020
17
0.180
Why?
Physician-Patient Relations
1
2021
43
0.180
Why?
Disease Outbreaks
1
2021
81
0.180
Why?
Hyperlipidemias
1
2020
19
0.180
Why?
Periodicals as Topic
1
2021
39
0.180
Why?
Postoperative Hemorrhage
1
2020
24
0.180
Why?
Endovascular Procedures
1
2020
32
0.180
Why?
Accidental Falls
1
2022
114
0.180
Why?
Myocardial Revascularization
1
2020
16
0.180
Why?
Postnatal Care
1
2020
7
0.170
Why?
Delivery, Obstetric
1
2020
12
0.170
Why?
Radiation-Protective Agents
1
2020
4
0.170
Why?
Protective Factors
1
2020
23
0.170
Why?
Colchicine
1
2020
10
0.170
Why?
Odds Ratio
2
2020
269
0.170
Why?
Thrombolytic Therapy
1
2020
46
0.170
Why?
Heart Valve Prosthesis Implantation
1
2020
28
0.170
Why?
Social Class
1
2020
68
0.170
Why?
Clinical Trials as Topic
1
2021
234
0.170
Why?
Infant, Newborn
1
2022
660
0.170
Why?
Income
1
2020
79
0.170
Why?
Prostatic Neoplasms
1
2021
104
0.170
Why?
After-Hours Care
1
2019
1
0.170
Why?
Global Health
1
2019
42
0.170
Why?
Radiation Injuries
1
2020
32
0.170
Why?
Cardiac Resynchronization Therapy
1
2019
12
0.170
Why?
Health Behavior
1
2020
164
0.160
Why?
Up-Regulation
2
2021
180
0.160
Why?
Multimodal Imaging
1
2019
28
0.160
Why?
Heart
1
2019
67
0.160
Why?
Treatment Refusal
1
2018
11
0.160
Why?
Heart Transplantation
1
1998
30
0.150
Why?
Intensive Care Units
1
2021
292
0.150
Why?
Asia, Western
1
2018
2
0.150
Why?
Indian Ocean Islands
1
2018
2
0.150
Why?
Surveys and Questionnaires
3
2022
1201
0.150
Why?
Reproducibility of Results
3
2017
715
0.150
Why?
Procainamide
1
1998
1
0.150
Why?
Atrial Flutter
1
1998
5
0.150
Why?
Graft Rejection
1
1998
71
0.150
Why?
Tachycardia
2
2021
10
0.150
Why?
Walking
1
2020
260
0.150
Why?
Sulfonamides
1
1998
41
0.150
Why?
Memory Disorders
1
2019
168
0.150
Why?
Diagnosis, Differential
1
2019
370
0.150
Why?
Inpatients
1
2019
149
0.150
Why?
Coronary Disease
2
2020
57
0.140
Why?
Echocardiography
4
2023
91
0.140
Why?
Lupus Erythematosus, Systemic
1
2020
192
0.140
Why?
Diet Surveys
1
2017
25
0.140
Why?
Patient Discharge
1
2018
162
0.140
Why?
Evidence-Based Medicine
1
2018
196
0.140
Why?
Rivaroxaban
1
2016
5
0.140
Why?
Dabigatran
1
2016
5
0.140
Why?
Thiazoles
1
2016
19
0.140
Why?
Nutrition Assessment
1
2017
43
0.140
Why?
Neoplasms
1
2020
236
0.140
Why?
Pyridones
1
2016
11
0.140
Why?
Evidence-Based Practice
1
2017
85
0.140
Why?
Pyridines
1
2016
37
0.140
Why?
Patient Selection
2
2020
207
0.140
Why?
Coronary Vessels
2
2021
34
0.130
Why?
Sensitivity and Specificity
2
2015
511
0.130
Why?
Georgia
1
2016
11
0.130
Why?
Dementia
1
2022
569
0.130
Why?
Platelet Aggregation Inhibitors
1
2016
48
0.130
Why?
Cholesterol, LDL
1
2016
31
0.130
Why?
Pyrazoles
1
2016
58
0.130
Why?
Self Efficacy
1
2016
60
0.130
Why?
Health Surveys
1
2016
90
0.130
Why?
Chicago
2
2016
905
0.130
Why?
Diet, Mediterranean
1
2017
92
0.120
Why?
Equipment Design
2
2015
153
0.120
Why?
Miniaturization
1
2015
2
0.120
Why?
Preventive Health Services
1
2015
15
0.120
Why?
Heart Rate
2
2009
115
0.120
Why?
Equipment Failure Analysis
1
2015
110
0.120
Why?
Smoking
2
2018
177
0.110
Why?
Cardiac Pacing, Artificial
2
1992
22
0.110
Why?
Needs Assessment
1
2013
42
0.110
Why?
Drug Monitoring
1
2012
17
0.100
Why?
Heart Conduction System
1
1992
11
0.100
Why?
Activities of Daily Living
1
2016
540
0.100
Why?
Data Collection
1
2012
98
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
70
0.100
Why?
Registries
3
2022
182
0.100
Why?
Blood Pressure
2
2023
202
0.090
Why?
Motor Activity
1
2013
331
0.090
Why?
Coronary Artery Bypass
2
2020
27
0.080
Why?
Survival Rate
2
2019
355
0.080
Why?
Databases, Factual
2
2019
354
0.070
Why?
Severity of Illness Index
2
2021
991
0.070
Why?
Azetidines
1
2006
2
0.070
Why?
Benzylamines
1
2006
10
0.070
Why?
Time Factors
3
2021
1489
0.070
Why?
Body Mass Index
2
2020
435
0.060
Why?
Endpoint Determination
1
2004
22
0.060
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
3
0.050
Why?
Postoperative Complications
2
2020
930
0.050
Why?
Brain-Derived Neurotrophic Factor
1
2024
47
0.050
Why?
Pharmacists
1
2023
19
0.050
Why?
Follow-Up Studies
2
2019
1811
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2022
3
0.050
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
22
0.050
Why?
Double-Blind Method
2
2006
424
0.050
Why?
Flecainide
1
2021
1
0.050
Why?
Genetic Testing
1
2022
58
0.050
Why?
Microcirculation
1
2021
29
0.050
Why?
Ischemia
1
2021
23
0.050
Why?
Delivery of Health Care
1
2023
154
0.050
Why?
Diuretics
1
2021
6
0.050
Why?
Pregnancy, High-Risk
1
2021
2
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Chlorides
1
2021
26
0.050
Why?
Recurrence
2
2006
318
0.050
Why?
Health Services Research
1
2021
42
0.050
Why?
Sodium
1
2021
62
0.050
Why?
Patient Preference
1
2021
33
0.040
Why?
Education, Medical
1
2021
41
0.040
Why?
Hypercholesterolemia
1
2020
27
0.040
Why?
Fetal Growth Retardation
1
2020
3
0.040
Why?
Polycystic Ovary Syndrome
1
2020
2
0.040
Why?
Lactation
1
2021
61
0.040
Why?
Abortion, Spontaneous
1
2020
4
0.040
Why?
Menopause, Premature
1
2020
6
0.040
Why?
Case-Control Studies
2
2000
585
0.040
Why?
Clinical Decision-Making
1
2020
41
0.040
Why?
Sleep Apnea, Central
1
2000
30
0.040
Why?
Health Care Costs
1
2020
79
0.040
Why?
Radiotherapy
1
2020
34
0.040
Why?
Attitude to Health
1
2020
106
0.040
Why?
Curriculum
1
2021
152
0.040
Why?
Costs and Cost Analysis
1
2019
35
0.040
Why?
Neuropsychological Tests
1
2024
1258
0.040
Why?
Autoimmune Diseases
1
2020
47
0.040
Why?
Thrombectomy
1
2019
29
0.040
Why?
Disease Management
1
2020
114
0.040
Why?
Multivariate Analysis
1
2020
321
0.040
Why?
Cause of Death
1
2019
64
0.040
Why?
Psychology
1
2018
24
0.040
Why?
Health Services Needs and Demand
1
2018
58
0.040
Why?
Heredity
1
2018
7
0.040
Why?
Cancer Survivors
1
2018
12
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
184
0.040
Why?
Diet, Western
1
2017
12
0.030
Why?
Quality Improvement
1
2018
161
0.030
Why?
Breast Feeding
1
2018
168
0.030
Why?
Waist Circumference
1
2015
31
0.030
Why?
Drug Therapy, Combination
1
2016
184
0.030
Why?
Genetic Predisposition to Disease
1
2018
383
0.030
Why?
Risk
1
2016
206
0.030
Why?
Body Composition
1
2016
69
0.030
Why?
Body Weight
1
2016
141
0.030
Why?
Decision Making
1
2018
229
0.030
Why?
Patient Compliance
1
2016
163
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
1
0.030
Why?
Dextroamphetamine
1
1993
2
0.030
Why?
Hypotension, Orthostatic
1
1993
11
0.030
Why?
Syncope
1
1993
5
0.030
Why?
Social Networking
1
2013
11
0.030
Why?
Efficiency
1
2013
19
0.030
Why?
Albuterol
1
1993
19
0.030
Why?
Bradycardia
1
1993
25
0.030
Why?
Interviews as Topic
1
2013
135
0.030
Why?
Program Evaluation
1
2013
136
0.030
Why?
Tachycardia, Ventricular
1
1992
23
0.030
Why?
Cardiac Catheterization
1
1992
70
0.020
Why?
Animals
1
2020
3828
0.020
Why?
Asthma
1
1993
163
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2006
7
0.020
Why?
Estrogen Replacement Therapy
1
2006
20
0.020
Why?
Thromboembolism
1
2006
17
0.020
Why?
Chi-Square Distribution
1
2006
145
0.020
Why?
Proportional Hazards Models
1
2006
344
0.010
Why?
Combined Modality Therapy
1
2004
306
0.010
Why?
Electrocardiography, Ambulatory
1
2000
10
0.010
Why?
Bronchoscopy
1
2000
34
0.010
Why?
Tracheostomy
1
2000
27
0.010
Why?
Respiration
1
2000
33
0.010
Why?
Anesthesia
1
2000
31
0.010
Why?
Child
1
2000
1410
0.010
Why?
False Positive Reactions
1
1993
36
0.010
Why?
Contraindications
1
1993
33
0.010
Why?
Action Potentials
1
1993
88
0.010
Why?
Administration, Inhalation
1
1993
45
0.010
Why?
Posture
1
1993
68
0.010
Why?
ROC Curve
1
1992
141
0.010
Why?
Analysis of Variance
1
1992
275
0.010
Why?
Volgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (370)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_